Unresolved issues in anthelmintic pharmacology for helminthiases of humans

International Journal for Parasitology

Volumn 40, Issue 1, 2010, Pages 1-13

  Geary, Timothy G ^a   Woo, Katherine ^b   McCarthy, James S ^c   Mackenzie, Charles D ^d   Horton, John ^e   Prichard, Roger K ^a   de Silva, Nilanthi R ^f   Olliaro, Piero L ^g   Lazdins Helds, Janis K ^g   Engels, Dirk A ^g   Bundy, Donald A ^h  

^a MCGILL UNIVERSITY   (Canada)

^b Institute for OneWorld Health   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e Tropical Projects   (United Kingdom)

^f UNIVERSITY OF KELANIYA   (Sri Lanka)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h WORLD BANK   (United States)

Author keywords

Anthelmintics; Lymphatic filariasis; Mass drug administration; Onchocerciasis; Pharmacology; Schistosomiasis; Soil transmitted helminths

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ARTEMISININ DERIVATIVE; DIETHYLCARBAMAZINE; DORAMECTIN; EMODEPSIDE; FEBANTEL; FLUBENDAZOLE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; MEFLOQUINE; METRIFONATE; MONEPANTEL; MOXIDECTIN; NITAZOXANIDE; OXAMNIQUINE; OXANTEL; PRAZIQUANTEL; PYRANTEL EMBONATE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; TRIBENDIMIDINE; UNCLASSIFIED DRUG;

DISEASE CONTROL; DISEASE TREATMENT; DRUG PRESCRIBING; DRUG RESISTANCE; LITERATURE REVIEW; LOW INCOME POPULATION; ONCHOCERCIASIS; PUBLIC HEALTH; SCHISTOSOMIASIS;

ASCARIASIS; BRAIN DISEASE; BRUGIA MALAYI; CAENORHABDITIS ELEGANS; CESTODIASIS; CRYPTOSPORIDIOSIS; DIROFILARIA IMMITIS; DIROFILARIASIS; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; FASCIOLIASIS; FILARIASIS; GIARDIASIS; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; IMMUNE RESPONSE; INJECTION SITE PAIN; INJECTION SITE REACTION; LOA LOA; LYMPHATIC FILARIASIS; MICROFILARIA (NEMATODE LARVA); NEMATODIASIS; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPTIMAL DRUG DOSE; PARASITE CONTROL; PARASITE TRANSMISSION; PATIENT COMPLIANCE; PLASMA HALF LIFE; REVIEW; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SOIL MICROFLORA; TRICHURIASIS; VETERINARY MEDICINE; WOLBACHIA;

ADULT; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG DESIGN; DRUG RESISTANCE; FEMALE; HELMINTHIASIS; HUMANS;

VERMES;

EID: 72049094540     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2009.11.001     Document Type: Review

References (122)

1. Albonico M., Crompton D.W., and Savioli L. Control strategies for human intestinal nematode infections. Adv. Parasitol. 42 (1999) 277-341
2. Albonico M., Bickle Q., Ramsan M., Montresor A., Savioli L., and Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. WHO 81 (2003) 343-352
3. Albonico M., Engels D., and Savioli L. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int. J. Parasitol. 34 (2004) 1205-1210
4. Albonico M., Wright V., Ramsan M., Haji H.J., Taylor M., Savioli L., and Bickle Q. Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms. Int. J. Parasitol. 35 (2005) 803-811
5. Ali M.M.M., Mukhtar M.M., Baraka O.Z., Homeida M.M.A., Kheir M.M., and Mackenzie C.D. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop. 84 (2002) 49-53
6. Anderson R.M., and Schad G.A. Hookworm infections and faecal egg counts: an analysis of the biological basis of variation. Trans. R. Soc. Trop. Med. Hyg. 79 (1985) 812-825
7. Ballweber L.R. Endoparasite control. Vet. Clin. North Am. Food Anim. Pract. 22 (2006) 451-461
8. Barnes T.M., and Hekimi S. The Caenorhabditis elegans avermectin resistance and anesthetic response gene unc-9 encodes a member of a protein family implicated in electrical coupling of excitable cells. J. Neurochem. 69 (1997) 2251-2260
9. Behnke J.M., Rose R., and Garside P. Sensitivity to ivermectin and pyrantel of Ancylostoma ceylonicum and Necator americanus. Int. J. Parasitol. 23 (1993) 945-952
10. Belizario V.Y., Amarillo M.E., de Leon W.U., de los Reyes A.E., Bugayong M.G., and Macatangay B.J.C. A comparison of the efficacy of single doses of albendazole, ivermectin and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull. WHO 81 (2003) 35-42
11. Bennett A., and Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol. Today 16 (2000) 71-74
12. Bennett J.L., Williams J.F., and Dave V. Pharmacology of ivermectin. Parasitol. Today 4 (1993) 226-228
13. Bergquist R., Johansen M.V., and Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 25 (2009) 151-156
14. Bird A.C., El Sheikh H., Anderson J., and Fuglsang H. Changes in visual function and in the posterior segment of the eye during the treatment of onchocerciasis with diethylcarbamazine citrate. Br. J. Ophthalmol. 64 (1980) 191-200
15. Botros S.S., and Bennett J.L. Praziquantel resistance. Curr. Opin. Drug Disc. 2 Suppl. 1 (2007) S35-S40
16. Brooker S., Clements A.C.A., and Bundy D.A.P. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv. Parasitol. 62 (2006) 221-261
17. Brown K.R. The use of macrocyclic lactones to control parasites of humans. In: Vercruysse J., and Rew R.S. (Eds). Macrocyclic Lactones in Antiparasitic Therapy (2002), CABI Publishing, NY 405-412
18. Brown K.R., Ricci F.M., and Ottesen E.A. Ivermectin: effectiveness in lymphatic filariasis. Parasitology 121 Suppl. (2000) S133-S146
19. Caffrey C.R. Chemotherapy of schistosomiasis: present and future. Curr. Opin. Chem. Biol. 11 (2007) 433-439
20. Castro N., Medina R., Sotelo J., and Jung H. Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob. Agents Chemother. 44 (2000) 2903-2904
21. Cioli D., Pica-Mattoccia L., and Archer S. Antischistosomal drugs: past, present...and future?. Pharmacol. Ther. 68 (1995) 35-85
22. Conder G.A., and Campbell W.C. Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance. Adv. Parasitol. 35 (1995) 1-84
23. Cotreau M.M., Warren S., Ryan J.L., Fleckenstein L., Vanapali S.R., Brown K.R., Rock D., Chen C.Y., and Schwertschlag U.S. The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J. Clin. Pharmacol. 43 (2003) 1108-1115
24. Critchley J., Addis D., Ejera H., Gamble C., Garner P., and Gelband H. Albendazole for the control and elimination of lymphatic filariasis: systematic review. Trop. Med. Int. Health 10 (2005) 818-825
25. Danso-Appiah A., Garner P., Olliaro P., and Utzinger J. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology 136 (2009) 1-13
26. Day T.A., Bennett J.L., and Pax R.A. Praziquantel: the enigmatic anthelmintic. Parasitol. Today 8 (1992) 342-344
27. Dayan A.D. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop. 86 (2003) 141-159
28. de C Bronsvoort B.M., Renz A., Tchakouté V., Tanya V.N., Ekale D., and Trees A.J. Repeated high doses of avermectins cause prolonged sterilization, but do not kill, Onchocerca ochengi adult worms in African cattle. Filaria J. 4 (2005) 4-8
29. de Silva N., Guyatt H., and Bundy D. Anthelmintics: a comparative review of their clinical pharmacology. Drugs 53 (1997) 769-788
30. Denham D.A., Samad R., Cho S.Y., Suswillo R.R., and Skippins S.C. The anthelmintic of flubendazole on Brugia pahangi. Trans. R. Soc. Trop. Med. Hyg. 73 (1979) 673-676
31. Diawara A., Drake L.J., Suswillo R.R., Kihara J., Bundy D.A.P., Scott M.E., Halpenny C., Stothard J.R., and Prichard R.K. Assays to detect β-tubulin codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides. PLoS Negl. Trop. Dis. 3 (2009) e397
32. Doenhoff M.J., Modha J., Lambertucci J.R., and McLaren D.J. The immune dependence of chemotherapy. Parasitol. Today 7 (1991) 16-18
33. Doenhoff M.J., Cioli D., and Utzinger J. Praziquantel: mechanism of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Inf. Dis. 21 (2008) 659-667
34. Dominguez-Vazquez A., Taylor H.R., Greene B.M., Ruvalcaba-Macias A.M., Rivas-Alcala A.R., Murphy R.P., and Beltran-Hernandez F. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Lancet 1 8317 (1983) 139-143
35. Drake L.J., and Bundy D.A. Multiple helminth infections in children: impact and control. Parasitology 122 Suppl. (2001) S73-S81
36. Duke B.O.L., Pacqué M.C., Muñoz B., Greene B.M., and Taylor H.R. Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin. Bull. WHO 69 (1991) 163-168
37. Eng J.K.L., Blackhall W.J., Osei-Atweneboana M.Y., Bourguinat C., Galazzo D., Beech R.N., Unnasch T.R., Awadzi K., Lubega G.W., and Prichard R.K. Ivermectin selection on β-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol. 150 (2006) 229-235
38. Engels D., and Savioli L. Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol. 22 (2006) 363-366
39. Ezeamama A.E., Friedman J.F., Olveda R.M., Acosta L.P., Kurtis J.D., Mor V., and McGarvey S.T. Functional significance of low-intensity polyparasite helminth infections in anemia. J. Infect. Dis. 192 (2005) 2160-2170
40. Fallon P.G., and Doenhoff M.J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51 (1994) 83-88
41. Forrester J.E., Bailar III J.C., Esrey S.A., Jose M.V., Castillejos B.T., and Ocampo G. Randomised trial of albendazole and pyrantel in symptomless trichuriasis in children. Lancet 352 (1998) 1103-1108
42. Fox L.M., and Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Inf. Dis. 40 (2005) 1173-1180
43. Garcia H.H., Moro P.L., and Schantz P.M. Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis. Curr. Opin. Inf. Dis. 20 (2007) 489-494
44. Gardon J., Gardon-Wendel N., Demanga-Ngangue, Kamgno J., Chippaux J.P., and Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 (1997) 18-22
45. Gardon J., Boussinesq M., Kamgno J., Gardon-Wendel N., Demanga-Nganque, and Duke B.O. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomized controlled trial. Lancet 360 (2002) 203-210
46. Geary T.G. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. 21 (2005) 530-532
47. Geerts S., and Gryseels B. Anthelmintic resistance in human helminths: a review. Trop. Med. Int. Health 6 (2001) 915-921
48. Ginger C.D. Advances in filarial chemotherapy and screening. Parasitol. Today 2 (1986) 38-40
49. Greene B.M. Diethylcarbamazine. Antimicrob. Agents Ann. 1 (1986) 258-264
50. Greene B.M., Brown K.R., and Taylor H.R. Use of ivermectin in humans. In: Campbell W.C. (Ed). Ivermectin and Avermectins (1989), Springer-Verlag, NY 311-323
51. Gross S.J., Ryan W.G., and Ploeger H.W. Anthelmintic treatment of dairy cows and its effect on milk production. Vet. Rec. 144 (1999) 581-587
52. Guest M., Bull K., Walker R.J., Amliwala K., O'Connor V., Harder A., Holden-Dye L., and Hopper N.A. The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans. Int. J. Parasitol. 37 (2007) 1577-1588
53. Gutteridge W.E., Hudson A.T., and Jenkins D.C. The Wellcome Foundation/World Health Organisation Onchocerciasis Chemotherapy Project Joint Programme to discover and develop a macrofilaricide for onchocerciasis. Acta Leidensia 59 (1990) 343-360
54. Gyapong J.O., Kumaraswami V., Biswas G., and Ottesen E.A. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Exp. Opin. Pharmacother. 6 (2005) 179-200
55. Hoerauf A. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr. Opin. Inf. Dis. 21 (2008) 673-681
56. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 121 Suppl. (2000) S113-S132
57. Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J., and Jacobson J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118 (2008) 1311-1321
58. Hu Y., Xiao S.-H., and Aroian R.V. The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist. PLoS Negl. Trop. Dis. 3 (2009) e499
59. Ismail M.M., and Jayakody R.L. Efficacy of albendazole and its combination with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka. Ann. Trop. Med. Parasitol. 93 (1999) 501-504
60. Jeziorski M.C., and Greenberg R.M. Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int. J. Parasitol. 36 (2006) 625-632
61. Junnila A., Bohle S., Prichard R., Perepichka I., and Spina C. Fluorescent diethylcarbamazine analogs: sites of accumulation in Brugia malayi. Bioconjug. Chem. 18 (2007) 1818-1823
62. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Weber S.S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., and Mäser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 452 (2008) 176-180
63. Kaminsky R., Mosimann D., Sager H., Stein P., and Hosking B. Determination of the effective dose rate for monepantel (AAD 1566) against adult gastro-intestinal nematodes in sheep. Int. J. Parasitol. 39 (2009) 443-446
64. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 20 (2004) 477-481
65. Keiser J., and Utzinger J. Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr. Opin. Inf. Dis. 20 (2007) 605-612
66. Keiser J., and Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections. Systematic review and meta-analysis. J. Am. Med. Assoc. 299 (2008) 1932-1948
67. Keiser J., Chollet J., Xiao S.H., Mei J.Y., Jiao P.Y., Utzinger J., and Tanner M. Mefloquine - an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. 3 (2009) e350
68. Kotze A.C., Coleman G.T., Mai A., and McCarthy J.S. Field evaluation of anthelmintic drug sensitivity using in vitro egg hatch and larval motility assays with Necator americanus recovered from human clinical isolates. Int. J. Parasitol. 35 (2005) 445-453
69. Kotze A.C., and Kopp S.R. The potential impact of density dependent fecundity on the use of the faecal egg count reduction test for detecting drug resistance in human hookworms. PLoS Negl. Trop. Dis. 2 (2008) e297
70. Kotze A.C., Lowe A., O'Grady J., Kopp S.R., and Behnke J.M. Dose-response assay templates for in vitro assessment of resistance to benzimidazole and nicotinic acetylcholine receptor agonist drugs in human hookworms. Am. J. Trop. Med. Hyg. 81 (2009) 163-170
71. Kshirsagar N.A., Gogtay N.J., Garg B.S., Deshmukh P.R., Rajgor D.D., Kadam V.S., Kirodian B.G., Ingole N.S., Mehendale A.M., Fleckenstein L., Karbwang J., and Lazdins-Held J.K. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 205-217
72. Kwa M.S., Veenstra J.G., and Roos M.H. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in b-tubulin isotype 1. Mol. Biochem. Parasitol. 63 (1994) 299-303
73. Leopold G., Ungethüm W., Groll E., Diekmann H.W., Nowak H., and Wegner D.H.G. Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. Eur. J. Clin. Pharmacol. 14 (1978) 281-291
74. Li X.Q., Björkman A., Andersson T.B., Gustafsson L.L., and Masimirembwa C.M. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur. J. Clin. Pharmacol. 59 (2003) 429-442
75. Lok J.B., Knight D.H., Selavka C.M., Eynard J., Zhang Y., and Bergman R.N. Studies of reproductive competence in male Dirofilaria immitis treated with milbemycin oxime. Trop. Med. Parasitol. 46 (1995) 235-240
76. Mackenzie C.D., and Kron M.A. Diethylcarbamazine: a review of its action in onchocerciasis, lymphatic filariasis and inflammation. Trop. Dis. Bull. 82 (1985) R1-R37
77. Mackenzie C.D., Geary T.G., and Gerlach J.A. Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J. 2 Suppl. 1 (2003) S5
78. Mackenzie C., Geary T., Prichard R., and Boussinesq M. Where next with Loa loa encephalopathy? Data are badly needed. Trends Parasitol. 23 (2007) 237-238
79. Maizels R.M., and Denham D.A. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 105 Suppl. (1992) S49-S60
80. Mak J.W., Navaratnam V., and Ramachandran C.P. Experimental chemotherapy of lymphatic filariasis. A review. Ann. Trop. Med. Parasitol. 85 (1991) 131-137
81. Mandour M.E., el Turabi H., Homeida M.M., el Sadig T., Ali H.M., Bennett J.L., Leahey W.J., and Harron D.W. Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 389-393
82. Martin R.J., Robertson A.P., and Bjorn H. Target sites of anthelmintics. Parasitology 114 Suppl. (1997) S111-S124
83. McCall J.W. The safety-net story about macrocyclic lactone heartworm preventatives: a review, an update and recommendations. Vet. Parasitol. 133 (2005) 197-206
84. McGarry H.F., Plant L.D., and Taylor M.J. Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J. 4 (2005) 4
85. Molyneux D.H., Hotez P.J., and Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2 (2005) e336
86. Mottier M.L., and Prichard R.K. Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus. Pharmacogenet. Genomics 18 (2008) 129-140
87. Noroes J., Dreyer G., Santos A., Mendes V.G., Medeiros Z., and Addiss D. Assessment of the effect of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 78-81
88. Nwaka S., and Hudson A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Disc. 5 (2006) 941-955
89. Olsen A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 747-758
90. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., Gyapong J.O., and Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369 (2007) 2021-2029
91. Pax R.A., Williams J.F., and Guderian R.H. In vitro motility of isolated adults and segments of Onchocerca volvulus, Brugia pahangi and Acanthocheilonema viteae. Trop. Med. Parasitol. 39 Suppl. (1988) 450-455
92. Plaisier A.P., Stolk W.A., van Oortmarssen G.J., and Habbema J.D.F. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol. Today 16 (2000) 298-302
93. Pullan R., and Brooker S. The health impact of polyparasitism in humans: are we under-estimating the burden of parasitic diseases?. Parasitology 135 (2008) 783-794
94. Ramirez B., Bickle Q., Yousif Y., Fakorede F., Mouries M.-A., and Nwaka S. Schistosomes: challenges in compound screening. Exp. Opin. Drug Disc. 2 Suppl. 1 (2007) S53-S61
95. Reddy M., Gill S.S., Kalkar S.R., Wu W., Anderson P.J., and Rochon P.A. Oral drug therapy for multiple neglected tropical diseases. A systematic review. J. Am. Med. Assoc. 298 (2007) 1911-1924
96. Ribeiro-dos-Santos G., Verjovski-Almeida S., and Leite L.C.C. Schistosomiasis - a century searching for chemotherapeutic drugs. Parasitol. Res. 99 (2006) 505-521
97. Richards J.C., Behnke J.M., and Duce I.R. In vitro studies on the relative sensitivity to ivermectin of Necator americanus and Ancylostoma ceylonicum. Int. J. Parasitol. 25 (1995) 1185-1191
98. Satti M.Z., VandeWaa E.A., Bennett J.L., Williams J.F., Conder G.A., and McCall J.W. Comparative effects of anthelmintics on motility in vitro of Onchocerca gutterosa, Brugia pahangi and Acanthocheilonema viteae. Trop. Med. Parasitol. 39 Suppl. (1988) 480-483
99. Schwab A.E., Churcher T.S., Schwab A.J., Basáñez M.-G., and Prichard R.K. An analysis of the population genetics of potential multi-drug resistance in lymphatic filariasis due to combination chemotherapy. Parasitology 134 (2007) 1025-1040
100. Scientific Working Group on Serious Adverse Events in Loa loa Endemic Areas, 2003. Report of a scientific working group on serious adverse events following Mectizan treatment of onchocerciasis in Loa loa endemic areas. Filaria J. 2 (Suppl. 1), S2.
101. Sharma S. Drugs for filariasis: four decades of research. Adv. Drug Res. 24 (1993) 199-260
102. Smith G., Grenfell B.T., Isham V., and Cornell S. Anthelmintic resistance revisited: under-dosing, chemoprophylactic strategies, and mating probabilities. Int. J. Parasitol. 29 (1999) 77-91
103. Steinmann P., Zhou X.N., Du Z.W., Jiang J.Y., Xiao S.H., Wu Z.X., Zhou H., and Utzinger J. Tribendimidine and albendazole for treating soil-transmitted helminths. Strongyloides stercoralis and Taenia spp.: open-label randomized trial. PLoS Negl. Trop. Dis. 2 (2008) e322
104. Stephenson L.S., Latham M.C., and Ottesen E.A. Malnutrition and parasitic helminth infections. Parasitology 121 Suppl. (2000) S23-S38
105. Stephenson L.S., Holland C.V., and Cooper E.S. The public health significance of Trichuris trichiura. Parasitology 121 Suppl. (2000) S73-S95
106. Surin J., and Denham D.A. Comparative susceptibility to anthelmintics of Brugia pahangi in jirds infected by different methods. J. Helminthol. 64 (1990) 232-238
107. Taylor M.J., Bandi C., and Hoerauf A. Wolbachia bacterial endosymbionts of filarial nematodes. Adv. Parasitol. 60 (2005) 247-286
108. Taylor M.J., Awadzi K., Basáñez M.-G., Biritwum N., Boakye D., Boatin B., Bockarie M., Churcher T.S., Debrah A., Edwards G., Hoerauf A., Mand S., Matthews G., Osei-Atweneboana M., Prichard R.K., Wanji S., and Adjei O. Onchocerciasis control: vision for the future from a Ghanaian perspective. Parasit. Vectors 2 (2009) 7
109. Tisch D.J., Michael E., and Kazura J.W. Mass chemotherapy options to control lymphatic filariasis: a systematic review. Lancet Infect. Dis. 5 (2005) 514-523
110. Townson S., Freeman A., Harris A., and Harder A. Activity of the cyclooctadepsipeptide emodepside against Onchocerca gutterosa, Onchocerca lienalis and Brugia pahangi. Am. J. Trop. Med. Hyg. 73 Suppl. (2005) 93
111. Townson S., Ramirez B., Fakorede F., Mouries M.-A., and Nwaka S. Challenges in drug discovery for novel antifilarials. Exp. Opin. Drug Disc. 2 Suppl. 1 (2007) S63-S73
112. Trees A.J., Graham S.P., Renz A., Bianco A.E., and Tanya V. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments. Parasitology 120 Suppl. (2000) S133-S142
113. Twum-Danso M.A.Y., and Meredith S.E.O. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loaisis. Trop. Med. Int. Health 8 (2003) 820-831
114. Utzinger J., and Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Exp. Opin. Pharmacother. 5 (2004) 263-285
115. Valle C., Troiani A.R., Festucci A., Pica-Mattoccia L., Liberti P., Wolstenholme A., Francklow K., Doenhoff M.J., and Cioli D. Sequence and level of endogenous expression of calcium channel β subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Mol. Biochem. Parasitol. 130 (2003) 111-115
116. van Wyk J.A. Refugia - overlooked as perhaps the most potent factor concerning the development of anthelmintic resistance. Onderstepoort J. Vet. Res. 68 (2001) 55-67
117. Vercruysse J., and Claerebout E. Treatment vs. non-treatment of helminth infections in cattle: defining the threshold. Vet. Parasitol. 98 (2001) 195-214
118. Wen L.Y., Yan X.L., Sun F.H., Fang Y.Y., Yang M.J., and Lou L.J. A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China. Acta Trop. 106 (2008) 190-194
119. Xiao S.H., Hui-Ming W., Tanner M., Utzinger J., and Chong W. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop. 94 (2005) 1-14
120. Zahner H., and Schares G. Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. Pahangi. Acta Trop. 52 (1993) 221-266
121. Zhang D., Zhang X., Tang Z., Chen C., Chen Y., Yang W., Jin M., Huang C., Yang G., and Long Y. Field trials on the efficacy of albendazole composite against intestinal nematodiasis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 16 (1998) 1-5
122. Zu L.Q., Jiang Z.X., Yu S.H., Ding X.M., Bin X.H., Yang H.F., Zhu H.Q., Kuang C.S., Chen Q.W., and Zhou C.H. Treatment of soil-transmitted helminth infections by anthelmintics in current use. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 10 (1992) 95-99